News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,358 Results
Type
Article (14379)
Company Profile (281)
Press Release (255698)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79986)
Career Advice (153)
Deals (13353)
Drug Delivery (35)
Drug Development (50788)
Employer Resources (31)
FDA (5787)
Job Trends (5179)
News (145483)
Policy (10176)
Tag
Academia (925)
Accelerated approval (2)
Adcomms (12)
Allergies (54)
Alliances (21798)
ALS (64)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (100)
Approvals (5819)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4600)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (165)
Cancer (1508)
Cardiovascular disease (118)
Career advice (134)
Career pathing (2)
CAR-T (118)
Cell therapy (332)
Cervical cancer (8)
Clinical research (41388)
Collaboration (547)
Compensation (263)
Complete response letters (13)
COVID-19 (1036)
CRISPR (42)
C-suite (166)
Cystic fibrosis (78)
Data (1544)
Denatured (11)
Depression (31)
Diabetes (142)
Diagnostics (1305)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (30066)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48912)
Executive appointments (465)
FDA (6504)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (257)
GLP-1 (366)
Government (1098)
Grass and pollen (2)
Guidances (28)
Healthcare (6642)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (93)
Indications (20)
Infectious disease (1102)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (17)
IPO (7336)
IRA (11)
Job creations (870)
Job search strategy (128)
Kidney cancer (7)
Labor market (5)
Layoffs (210)
Leadership (3)
Legal (1403)
Liver cancer (33)
Lung cancer (212)
Lymphoma (104)
Machine learning (3)
Management (7)
Manufacturing (142)
MASH (54)
Medical device (2643)
Medtech (2644)
Mergers & acquisitions (6351)
Metabolic disorders (394)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1265)
NextGen: Class of 2025 (2031)
Non-profit (856)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (64)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (131)
Patient recruitment (79)
Peanut (35)
People (25764)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14598)
Phase II (19211)
Phase III (12214)
Pipeline (830)
Policy (46)
Postmarket research (857)
Preclinical (6173)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (294)
Real estate (1428)
Recruiting (12)
Regulatory (8778)
Reports (15)
Research institute (944)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (61)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (118)
Sponsored (12)
Startups (1980)
State (1)
Stomach cancer (5)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (228)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (81)
Last 7 days (546)
Last 30 days (1509)
Last 365 days (19649)
2025 (6400)
2024 (20654)
2023 (22523)
2022 (26979)
2021 (27988)
2020 (23553)
2019 (16429)
2018 (11896)
2017 (13868)
2016 (11913)
2015 (14487)
2014 (10507)
2013 (7593)
2012 (7624)
2011 (7695)
2010 (7499)
Location
Africa (151)
Alabama (42)
Alaska (2)
Arizona (58)
Arkansas (6)
Asia (17574)
Australia (2953)
California (3889)
Canada (1146)
China (362)
Colorado (150)
Connecticut (152)
Delaware (103)
Europe (37549)
Florida (472)
Georgia (117)
Idaho (17)
Illinois (233)
India (10)
Indiana (92)
Iowa (2)
Japan (87)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (490)
Massachusetts (3111)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (15)
New Jersey (990)
New Mexico (12)
New York (1051)
North Carolina (557)
North Dakota (5)
Northern California (1719)
Ohio (113)
Oklahoma (9)
Oregon (22)
Pennsylvania (745)
Puerto Rico (6)
Rhode Island (19)
South America (209)
South Carolina (4)
Southern California (1496)
Tennessee (25)
Texas (456)
United States (13402)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (352)
Wisconsin (15)
270,358 Results for "tetra therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Medline to launch REFLEX® TETRA Nitinol Staples at AOFAS 2023 Annual Meeting
Attendees at this year’s American Orthopaedic Foot & Ankle Society annual meeting in Louisville, Kentucky will be the first to see Medline UNITE’s new REFLEX TETRA Nitinol Staples.
September 14, 2023
·
3 min read
Tetra Pharm Technologies inaugurates new R&D, manufacturing and production facility
The Danish biotech company, Tetra Pharm Technologies, announces completion of its new purpose-built headquarters facility to support long-term growth plans.
August 16, 2023
·
2 min read
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003
Tetra Bio-Pharma Inc. today announced the filing of three patent applications for its novel therapeutic, ARDS-003.
November 29, 2022
·
5 min read
Drug Development
Tetra Pharm Technologies concludes preclinical testing of TPT0301 in preparation of First-in-Human clinical trials
Following convincing results from a recent In-Vitro study, the Danish biotech company, Tetra Pharm Technologies, announces successful In-Vivo study results of its candidate compound, TPT0301.
September 6, 2023
·
2 min read
Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound
The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug - TPT0301.
June 13, 2023
·
2 min read
Innate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH6501 at the EHA 2023 Congress
Innate Pharma SA announced that updated preclinical data on its IPH6501 tetra-specific ANKET® are presented at the European Hematology Association 2023 congress.
June 10, 2023
·
5 min read
Genetown
Labforward Joins the Tetra Partner Network to Eliminate Data Silos and Error-Prone Data Transfers
TetraScience, the Scientific Data Cloud company, announced today that Labforward, a leader in optimizing laboratory workflows, has joined the Tetra Partner Network to enable scientists to maximize the value of their data utilizing the Tetra Scientific Data Cloud™.
January 12, 2023
·
3 min read
Tetra Pharm Technologies secures €9 million in Series A Round to expand R&D Operations
The Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors.
January 26, 2023
·
2 min read
Tetra Bio-Pharma Announces Listing to OTCPink Market
Tetra Bio-Pharma Inc. announced that its common shares began trading on the OTC Markets Group’s OTCPink Market in the United States under the symbol “TBPMF” effective at the opening of trading on Friday, February 10, 2023 and will continue to trade on the Toronto Stock Exchange under the ticker symbol “TBP”.
February 10, 2023
·
4 min read
Tetra Bio-Pharma Provides Update on Its REDUVO New Drug Submission
Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development is providing its shareholders with a regulatory status update on the REDUVO™ New Drug Submission (NDS).
November 18, 2022
·
4 min read
1 of 27,036
Next
